Mga Industriya

Showing 51–60 ng mga 134 results

  • Placeholder

    Hindi Maliit na Cell Lung Carcinoma (NSCLC) Market sa China

    Sa 3% CAGR, ang di maliit na selda lung carcinoma (NSCLC) merkado sa Tsina ay inaasahan na maabot 967 libong yunit sa pamamagitan ng 2027, ayon sa data at analytics company na StrategyHelix.

    USD 10
  • Placeholder

    Nasopharyngeal Cancer Market in China

    According to a statistic by StrategyHelix, the nasopharyngeal cancer market in China, sa dami ng mga tuntunin, is expected to expand at a CAGR of 1.2% sa susunod na limang taon.

    USD 5
  • Placeholder

    Head and Neck Cancer Market in China

    The head and neck cancer market in China, sa dami ng mga tuntunin, is expected to expand at a CAGR of 1.7% mula sa 2021 sa pamamagitan ng 2027, ayon sa data at analytics company na StrategyHelix.

    USD 5
  • Placeholder

    Global Immuno-Oncology Therapy Market

    The global immuno-oncology therapy market is expected to increase at a CAGR of 22.6% till 2027, ayon sa data at analytics company na StrategyHelix.

    USD 10
  • Placeholder

    Oncology Drug Market in China

    The oncology drug market in China is poised to grow at a CAGR of around 13.3% sa panahon ng pagsusuri ng 2021 sa 2027, ayon sa data at analytics company na StrategyHelix.

    USD 10
  • Placeholder

    Global Oncology Drug Market

    According to a statistic by StrategyHelix, the global oncology drug market is poised to grow at a CAGR of around 12.6% sa panahon ng pagsusuri ng 2021 sa 2027.

    USD 15
  • Placeholder

    Biomedical Materials Market in China

    A statistic by StrategyHelix indicates that the biomedical materials market in China is expected to increase at a CAGR of 11.5% till 2027.

    USD 15
  • Placeholder

    Home Use Medical Device Market in China

    The home use medical device market in China is set to increase by US$ 12,122 milyon mula sa 2021 sa 2027, representing a compound annual growth rate (CAGR) ng mga 10% sa panahon ng pagtataya.

    USD 5
  • Placeholder

    Blood Glucose Market in China

    The blood glucose market in China is poised to grow by US$ 18,136 milyon sa panahon ng 2021-2027, umuusad sa isang CAGR ng 22.8% sa panahon ng pagtataya, ayon sa data at analytics company na StrategyHelix.

    USD 10
  • Placeholder

    Nutritional Supplement Market in China

    The nutritional supplement market in China was around 233 m units in 2020, reached 272 m units in 2021 (an increase of 16.5% year-on-year), ayon sa StrategyHelix’ analysis.

    USD 5
Mag-scroll sa Itaas

mag-login